Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 24 Show results per page	View Search Criteria \| Help With Results

Last Modified: 9/13/2007 First Published: 1/5/2007


1.		Phase I/II Study of Paclitaxel and Ifosfamide Followed By Paclitaxel, Carboplatin, and Ifosfamide With Autologous Peripheral Blood Stem Cell Support in Patients With Cisplatin-Resistant Germ Cell Tumor

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 and over				NCI				MSKCC-06077 NCT00423852

Last Modified: 5/22/2008 First Published: 5/4/2007


2.		Phase II Pilot Study of Irradiated Allogeneic Related Donor Lymphocyte Infusion in Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Treatment				Active				Any age				NCI				CINJ-3330 NCT00161187

Last Modified: 8/5/2008 First Published: 5/1/2007


3.		Phase II Study of Combination Chemotherapy and Pegfilgrastim in Patients With Previously Untreated Germ Cell Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				NCI				MSKCC-07044 07-044, NCT00470366

Last Modified: 10/22/2008 First Published: 2/28/2008


4.		Phase II Study of Tandem High-Dose Chemotherapy in Combination With Autologous Hematopoietic Stem Cell Transplantation in Patients With Germ Cell Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				16 and over				NCI				CHNMC-07156 07156, NCT00627601


5.		Efficacy Study of Maintenance IT-101 Therapy for Ovarian Cancer Patients.

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 to 78				Pharmaceutical / Industry				OVAR0801 NCT00753740

Last Modified: 6/7/2007 First Published: 2/12/2007


6.		Phase I Study of Adjuvant pNGVL3-hICD Vaccine and Sargramostim in Patients With HER2/neu-Overexpressing Stage III or IV Breast or Ovarian Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Biomarker/Laboratory analysis, Treatment				Active				18 and over				NCI				UWASH-01-9773-D07 NCT00436254


7.		Phase I Study Using Sunitinib Plus Radiation Therapy for Cancer Patients

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Active				18 and over				Other				06C.549 NCT00437372


8.		A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Biomarker/Laboratory analysis, Treatment				Active				18 and over				Pharmaceutical / Industry				0602 Oral Picoplatin NCT00465725


9.		Topotecan, Ifosfamide and Carboplatin in Children and Young Adults With Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Active				45 and under				Other				2004-0079 NCT00502892


10.		Study of Safety and Tolerability of Intravenous CRS-207 in Adults With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard Treatment

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Active				18 and over				Pharmaceutical / Industry				VAC07001 NCT00585845

Select All on One Page


					1 2 3 Next >

| | | | | | | |

A Service of the National Cancer Institute